Lithium treatment duration

Lithium treatment duration has been studied in 1 paper since 2016: 1 observational study in people. The newest paper, Apr 12, 2016: “Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients”.

Exposure

1 paper studies it1 findingUpdated

“After correcting for age, LTL was positively correlated with lithium treatment duration in patients treated for more than two years (n=150, R=0.17, p=0.037).”
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patientsEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology2016doi:10.1016/j.euroneuro.2016.03.020
  • 1 lab in 1 country
  • Funder: McGill University
  • Humans1

What is Lithium treatment duration linked with?

1

Studies link Lithium treatment duration with 1 measure, most often telomere length (1 study).

Telomere length

upin humans1

1 study
  1. Lithium treatment duration is associated with telomere length in humans (R=0.17).

    “After correcting for age, LTL was positively correlated with lithium treatment duration in patients treated for more than two years (n=150, R=0.17, p=0.037).”

    Humansbipolar disorder; corrected for ageleukocytemore than two yearsn = 150

    Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients

    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

More on Telomere length

Latest